LANREOTIDE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | LANREOTIDE |
| DrugBank ID | DB06791 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 67 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| cushing syndrome | TxGNN Knowledge Graph | L5 |
| adrenal gland hyperfunction | TxGNN Knowledge Graph | L5 |
| esophageal candidiasis | TxGNN Knowledge Graph | L5 |
| leptospirosis | TxGNN Knowledge Graph | L5 |
| candidiasis | TxGNN Knowledge Graph | L5 |
| trypanosomiasis | TxGNN Knowledge Graph | L5 |
| cat-scratch disease | TxGNN Knowledge Graph | L5 |
| histoplasmosis | TxGNN Knowledge Graph | L5 |
| disseminated candidiasis | TxGNN Knowledge Graph | L5 |
| urinary tract infection (disease) | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11